 interpretive pitfalls arrhythmia suppression myocardial infarction insights long-term observations placebo-treated patients Cardiac Arrhythmia Pilot Study CAPS Cardiac Arrhythmia Pilot Study CAPS year trial safety effectiveness arrhythmia suppression patients acute myocardial infarction equal ventricular premature depolarizations/h equal runs ventricular tachycardia Holter recording days acute infarction patients placebo double-blind fashion year comprehensive objective analysis spontaneous arrhythmia changes real data statistical estimates CAPS placebo group serious clinical event year death heart failure proarrhythmia attributable antiarrhythmic drug toxicity significant reduction frequency ventricular premature depolarizations first weeks therapy significant decrease months initiation placebo antiarrhythmic therapy apparent ventricular premature depolarization suppression equal reduction Holter evaluation half Holter recordings suppression